Equillium to Participate in Upcoming Investor Conferences
Equillium to Participate in Upcoming Investor Conferences GlobeNewswire November 20, 2025 LA JOLLA, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming […]